Atropine 0.01% Eye Drops in Myopia Study

Summary

Atropine 0.01% Eye Drops in Myopia Study is a clinical trial^[1].

Key Facts

• Atropine 0.01% Eye Drops in Myopia Study is in the country of Oman^[2].
• Atropine 0.01% Eye Drops in Myopia Study's instance of is recorded as clinical trial^[3].
• Atropine 0.01% Eye Drops in Myopia Study's start time is recorded as +2018-12-01T00:00:00Z^[4].
• Atropine 0.01% Eye Drops in Myopia Study's end time is recorded as +2022-01-01T00:00:00Z^[5].
• Atropine 0.01% Eye Drops in Myopia Study's sponsor is recorded as Sultan Qaboos University^[6].
• Atropine 0.01% Eye Drops in Myopia Study's main subject is recorded as myopia^[7].
• Atropine 0.01% Eye Drops in Myopia Study's number of participants is recorded as {'unit': '1', 'amount': '+150'}^[8].
• Atropine 0.01% Eye Drops in Myopia Study's title is recorded as Randomized Clinical Trial on Atropine 0.01% for the Control of Myopia in Omani Children^[9].
• Atropine 0.01% Eye Drops in Myopia Study's short name is recorded as AIMS^[10].
• Atropine 0.01% Eye Drops in Myopia Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+6'}^[11].
• Atropine 0.01% Eye Drops in Myopia Study's ClinicalTrials.gov ID is recorded as NCT03508817^[12].
• Atropine 0.01% Eye Drops in Myopia Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+15'}^[13].
• Atropine 0.01% Eye Drops in Myopia Study's research intervention is recorded as eye drop^[14].
• Atropine 0.01% Eye Drops in Myopia Study's research intervention is recorded as atropine^[15].
• Atropine 0.01% Eye Drops in Myopia Study's clinical trial phase is recorded as phase I clinical trial^[16].
• Atropine 0.01% Eye Drops in Myopia Study's research site is recorded as Sultan Qaboos University^[17].
• Atropine 0.01% Eye Drops in Myopia Study's research subject recruitment status is recorded as recruiting^[18].
• Atropine 0.01% Eye Drops in Myopia Study's study type is recorded as interventional study^[19].